Impact of Antidepressant Use on Gastric Bypass Surgery Patients’ Weight Loss and Health-Related Quality-of-Life Outcomes
| Autor: | Ashley S. Love, Steven Bower, Walker S. Carlos Poston, Robert J. Love |
|---|---|
| Rok vydání: | 2008 |
| Předmět: |
Adult
Male medicine.medical_specialty Adolescent Health Status Gastric Bypass Comorbidity medicine.disease_cause Young Adult Arts and Humanities (miscellaneous) Weight loss Internal medicine Adaptation Psychological Weight Loss medicine Humans Applied Psychology Depression (differential diagnoses) Psychiatric Status Rating Scales Health related quality of life Analysis of Variance Depressive Disorder Gastric bypass surgery business.industry Outcome measures Middle Aged Texas Antidepressive Agents Obesity Morbid Surgery Psychiatry and Mental health Treatment Outcome Bypass surgery Quality of Life Antidepressant Female medicine.symptom business |
| Zdroj: | Psychosomatics. 49:478-486 |
| ISSN: | 0033-3182 |
| DOI: | 10.1176/appi.psy.49.6.478 |
| Popis: | Background Psychological factors may be predictive of post-surgical adjustment and successful outcomes in obesity-surgery populations. Objective The authors compared post–gastric bypass surgery (GBS) outcomes of patients being given active psychotropic treatment for depression, with those of patients without treatment or identifiable need for treatment at enrollment. Method Outcome measures included weight and repeated administration of the Medical Outcome Survey Short Form–36 (SF–36). Results There was no impact of antidepressant treatment on GBS patients’ weight loss or SF–36 outcomes. Conclusion Therefore, patients with actively treated depression should be expected to have GBS outcomes equivalent to those of patients without identifiable psychiatric illness or treatment. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect